This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Santa Clara, CA-based Agilent Technologies, Inc. was originally a spin-off from Hewlett-Packard. The company is an original equipment manufacturer (OEM) of a broad-based portfolio of test and measurement products serving multiple end markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG). The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers’ representatives, telesales and electronic commerce.
What's in Store for QuickLogic (QUIK) This Earnings Season?
by Zacks Equity Research
QuickLogic's (QUIK) first-quarter 2024 performance is likely to have gained from the growing adoption of its sensor processing solutions and embedded FPGA Intellectual Property Licensing platform.
DigitalOcean (DOCN) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
DigitalOcean's (DOCN) first-quarter 2024 performance is likely to reflect benefits from a robust product portfolio and strong demand for its cloud services.
What's in the Offing for Gen Digital (GEN) This Earnings Season?
by Zacks Equity Research
While the increased demand for cybersecurity and ID analytics solutions is expected to aid Gen Digital's (GEN) Q4 top line, higher interest expenses and the equity dilution impact are likely to have weighed on the bottom line.
Immersion (IMMR) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Immersion's (IMMR) first-quarter performance is likely to have gained from the new business wins and renewal of contracts in gaming, automotive and AR/VR space.
DHI Group (DHX) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
DHI Group's (DHX) first-quarter 2024 performance is likely to have benefited from its diversified portfolio and improvement in bookings environment across all new business divisions.
Perion Network (PERI) to Report Q1 Earnings: What to Expect
by Zacks Equity Research
Perion Network's (PERI) first-quarter earnings are expected to have benefited from its diversified portfolio in the advertising industry.
These 2 Computer and Technology Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Will Agilent (A) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Agilent (A) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Agilent Technologies (A) is a Top Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Cognex Corporation (CGNX) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Cognex (CGNX) delivered earnings and revenue surprises of 37.50% and 6.39%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Want Better Returns? Don?t Ignore These 2 Computer and Technology Stocks Set to Beat Earnings
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Waters (WAT) Boosts Waters Operating Segment With HPLC System
by Zacks Equity Research
Waters (WAT) launches Alliance iS Bio HPLC system to improve efficiency across biopharma QC laboratories, boosting its Waters Operating segment.
Agilent (A) is Set for Analytica 2024 With Advanced Products
by Zacks Equity Research
Agilent (A) plans to showcase its new products for analytical laboratories at Analytica 2024, boosting its overall product portfolio.
Agilent (A) to Bolster DCG Segment With Upcoming Solutions
by Zacks Equity Research
Agilent (A) plans to introduce new solutions for cancer research and diagnosis, boosting its DCG segment.
Agilent (A) Boosts LSAG Segment With Advanced Dilution System
by Zacks Equity Research
Agilent (A) unveils ADS 2 to enhance workflow efficiency within the laboratory, boosting the LSAG segment.
Earnings Growth & Price Strength Make Agilent Technologies (A) a Stock to Watch
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Agilent (A) Up 7.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
New to Investing? This 1 Computer and Technology Stock Could Be the Perfect Starting Point
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Why Agilent Technologies (A) is a Top Stock for the Long-Term
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Should You Invest in the First Trust Water ETF (FIW)?
by Zacks Equity Research
Sector ETF report for FIW
Agilent (A) Q1 Earnings & Revenues Beat Estimates, Dip Y/Y
by Zacks Equity Research
Agilent's (A) first-quarter fiscal 2024 results reflect softness across the LSAG and DGG segments. Weak momentum in China has been concerning.
Agilent (A) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Agilent (A) give insight into how the company performed in the quarter ended January 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Agilent Technologies (A) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Agilent (A) delivered earnings and revenue surprises of 6.61% and 5.53%, respectively, for the quarter ended January 2024. Do the numbers hold clues to what lies ahead for the stock?
Soft Landing Thesis In Tact As Inflation Cools Without Recession So Far
by Mayur Thaker
soft landing optimism continues to fuel the market rally, but with rapidly expanding valuation multiples that will challenge the dot com bubble era
3 Top-Rated Stocks to Consider as Earnings Approach
by Shaun Pruitt
With representation from a variety of sectors, several top-rated Zacks stocks look attractive ahead of their quarterly reports on Tuesday, February 27.